These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 25143433)

  • 1. Constitutively active ErbB2 regulates cisplatin-induced cell death in breast cancer cells via pro- and antiapoptotic mechanisms.
    Sigurðsson HH; Olesen CW; Dybboe R; Lauritzen G; Pedersen SF
    Mol Cancer Res; 2015 Jan; 13(1):63-77. PubMed ID: 25143433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NBCn1 and NHE1 expression and activity in DeltaNErbB2 receptor-expressing MCF-7 breast cancer cells: contributions to pHi regulation and chemotherapy resistance.
    Lauritzen G; Jensen MB; Boedtkjer E; Dybboe R; Aalkjaer C; Nylandsted J; Pedersen SF
    Exp Cell Res; 2010 Sep; 316(15):2538-53. PubMed ID: 20542029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Na+/H+ exchanger NHE1, but not the Na+, HCO3(-) cotransporter NBCn1, regulates motility of MCF7 breast cancer cells expressing constitutively active ErbB2.
    Lauritzen G; Stock CM; Lemaire J; Lund SF; Jensen MF; Damsgaard B; Petersen KS; Wiwel M; Rønnov-Jessen L; Schwab A; Pedersen SF
    Cancer Lett; 2012 Apr; 317(2):172-83. PubMed ID: 22120673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ErbB2 upregulates the Na+,HCO3(-)-cotransporter NBCn1/SLC4A7 in human breast cancer cells via Akt, ERK, Src, and Kruppel-like factor 4.
    Gorbatenko A; Olesen CW; Mørup N; Thiel G; Kallunki T; Valen E; Pedersen SF
    FASEB J; 2014 Jan; 28(1):350-63. PubMed ID: 24088818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Na
    Aaen P; Kristensen KB; Antony A; Hansen SH; Cornett C; Pedersen SF; Boedtkjer E
    Biochim Biophys Acta Mol Basis Dis; 2024 Oct; 1870(7):167450. PubMed ID: 39111631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of acid-extruding ion transporters in regulation of breast cancer cell growth in a 3-dimensional microenvironment.
    Andersen AP; Flinck M; Oernbo EK; Pedersen NB; Viuff BM; Pedersen SF
    Mol Cancer; 2016 Jun; 15(1):45. PubMed ID: 27266704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenic p95HER2 regulates Na+-HCO3- cotransporter NBCn1 mRNA stability in breast cancer cells via 3'UTR-dependent processes.
    Gorbatenko A; Olesen CW; Loebl N; Sigurdsson HH; Bianchi C; Pedraz-Cuesta E; Christiansen J; Pedersen SF
    Biochem J; 2016 Nov; 473(21):4027-4044. PubMed ID: 27609814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced sensitization to taxol-induced apoptosis by herceptin pretreatment in ErbB2-overexpressing breast cancer cells.
    Lee S; Yang W; Lan KH; Sellappan S; Klos K; Hortobagyi G; Hung MC; Yu D
    Cancer Res; 2002 Oct; 62(20):5703-10. PubMed ID: 12384528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of Na+,HCO3(-)-cotransport to cellular pH control in human breast cancer: a role for the breast cancer susceptibility locus NBCn1 (SLC4A7).
    Boedtkjer E; Moreira JM; Mele M; Vahl P; Wielenga VT; Christiansen PM; Jensen VE; Pedersen SF; Aalkjaer C
    Int J Cancer; 2013 Mar; 132(6):1288-99. PubMed ID: 22907202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The acid-base transport proteins NHE1 and NBCn1 regulate cell cycle progression in human breast cancer cells.
    Flinck M; Kramer SH; Schnipper J; Andersen AP; Pedersen SF
    Cell Cycle; 2018; 17(9):1056-1067. PubMed ID: 29895196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heregulin-triggered Her-2/neu signaling enhances nuclear accumulation of p21WAF1/CIP1 and protects breast cancer cells from cisplatin-induced genotoxic damage.
    Menendez JA; Mehmi I; Lupu R
    Int J Oncol; 2005 Mar; 26(3):649-59. PubMed ID: 15703820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Taxol-induced growth arrest and apoptosis is associated with the upregulation of the Cdk inhibitor, p21WAF1/CIP1, in human breast cancer cells.
    Choi YH; Yoo YH
    Oncol Rep; 2012 Dec; 28(6):2163-9. PubMed ID: 23023313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ErbB2 overexpression in human breast carcinoma is correlated with p21Cip1 up-regulation and tyrosine-15 hyperphosphorylation of p34Cdc2: poor responsiveness to chemotherapy with cyclophoshamide methotrexate, and 5-fluorouracil is associated with Erb2 overexpression and with p21Cip1 overexpression.
    Yang W; Klos KS; Zhou X; Yao J; Yang Y; Smith TL; Shi D; Yu D
    Cancer; 2003 Sep; 98(6):1123-30. PubMed ID: 12973835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-FdUrd-araC heterodinucleoside re-establishes sensitivity in 5-FdUrd- and AraC-resistant MCF-7 breast cancer cells overexpressing ErbB2.
    Strasser S; Maier S; Leisser C; Saiko P; Madlener S; Bader Y; Bernhaus A; Gueorguieva M; Richter S; Mader RM; Wesierska-Gadek J; Schott H; Szekeres T; Fritzer-Szekeres M; Krupitza G
    Differentiation; 2006 Dec; 74(9-10):488-98. PubMed ID: 17177846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the Na+/H+ Exchanger (NHE1) in Breast Cancer Metastasis.
    Amith SR; Fliegel L
    Cancer Res; 2013 Feb; 73(4):1259-64. PubMed ID: 23393197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trastuzumab in combination with heregulin-activated Her-2 (erbB-2) triggers a receptor-enhanced chemosensitivity effect in the absence of Her-2 overexpression.
    Menendez JA; Mehmi I; Lupu R
    J Clin Oncol; 2006 Aug; 24(23):3735-46. PubMed ID: 16847284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caveolin-1 inhibits cell detachment-induced p53 activation and anoikis by upregulation of insulin-like growth factor-I receptors and signaling.
    Ravid D; Maor S; Werner H; Liscovitch M
    Oncogene; 2005 Feb; 24(8):1338-47. PubMed ID: 15592498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Premature senescence is a primary fail-safe mechanism of ERBB2-driven tumorigenesis in breast carcinoma cells.
    Trost TM; Lausch EU; Fees SA; Schmitt S; Enklaar T; Reutzel D; Brixel LR; Schmidtke P; Maringer M; Schiffer IB; Heimerdinger CK; Hengstler JG; Fritz G; Bockamp EO; Prawitt D; Zabel BU; Spangenberg C
    Cancer Res; 2005 Feb; 65(3):840-9. PubMed ID: 15705882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated expression of erbB3 confers paclitaxel resistance in erbB2-overexpressing breast cancer cells via upregulation of Survivin.
    Wang S; Huang X; Lee CK; Liu B
    Oncogene; 2010 Jul; 29(29):4225-36. PubMed ID: 20498641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cisplatin-induced apoptosis involves membrane fluidification via inhibition of NHE1 in human colon cancer cells.
    Rebillard A; Tekpli X; Meurette O; Sergent O; LeMoigne-Muller G; Vernhet L; Gorria M; Chevanne M; Christmann M; Kaina B; Counillon L; Gulbins E; Lagadic-Gossmann D; Dimanche-Boitrel MT
    Cancer Res; 2007 Aug; 67(16):7865-74. PubMed ID: 17699793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.